The Novel l- and d-Amino Acid Derivatives of Hydroxyurea and Hydantoins: Synthesis, X-ray Crystal Structure Study, and Cytostatic and Antiviral Activity Evaluations
- 31 December 2004
- journal article
- research article
- Published by American Chemical Society (ACS) in Journal of Medicinal Chemistry
- Vol. 48 (2), 475-482
- https://doi.org/10.1021/jm040869i
Abstract
The novel l- and d-amino acid derivatives of hydroxyurea 5a − o were prepared by aminolysis of N-(1-benzotriazolecarbonyl)amino acid amides 4a − o with hydroxylamine. The hydantoin derivatives 6a − e,m,p were synthesized by base-catalyzed cyclization of amides 4, common precursors for 5 and 6. X-ray crystal structure analysis shows that the C5 atom in 6e possesses the S configuration, which is consistent with the configuration of the starting reagent, l-leucine. Among l-amino acid derivatives of hydroxyurea, 5h and 5i inhibited specifically murine leukemia and human T-lymphocytes (IC50 = 10−19 μM) and showed selectivity with respect to normal human fibroblasts (WI 38). d-Amino acid derivatives of hydroxyurea 5m and 5o inhibited the growth of all tumor cell lines (IC50 = 4.8−83.9 μM), but not the growth of normal fibroblasts (WI 38; IC50 > 100 μM). Results on antiviral evaluations showed that N-(1-benzotriazolecarbonyl)amino acid amide 4m and hydantoin 6m had marked activity against the Davis strain of CMV (4m, EC50 = 3.2 μg/mL; 6m, EC50 = 4.0 μg/mL). However, these compounds showed also rather expressed cytotoxicity (4m, CC50 = 43.4 μg/mL; 6m, CC50 = 12.5 μg/mL-1).Keywords
This publication has 5 references indexed in Scilit:
- PARST95 – an update to PARST: a system of Fortran routines for calculating molecular structure parameters from the results of crystal structure analysesJournal of Applied Crystallography, 1995
- Synergistic anti-human immunodeficiency virus type 1 effect of hydroxamate compounds with 2',3'-dideoxyinosine in infected resting human lymphocytes.Proceedings of the National Academy of Sciences of the United States of America, 1994
- Hydroxyurea as an Inhibitor of Human Immunodeficiency Virus-Type 1 ReplicationScience, 1994
- 9-(2-phosphonylmethoxyethyl)adenine (PMEA) effectively inhibits retrovirus replication in vitro and simian immunodeficiency virus infection in rhesus monkeysAIDS, 1991
- Suppression of mouse viraemia and retroviral disease by 3′-azido-3′-deoxythymidineNature, 1986